Skip to main content
. 2003 Jan;55(1):77–85. doi: 10.1046/j.1365-2125.2003.01731.x

Figure 1.

Figure 1

The disposition of chlorzoxazone following an oral 500-mg dose in ten healthy volunteers, 14 volunteers with Type I diabetes mellitus and eight volunteers with Type II diabetes mellitus. Each point represents the mean (± s.d.). •, Values for healthy volunteers; ○, values for patients with Type I diabetes mellitus; □, values for patients with Type II diabetes mellitus.